Overview

Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the ocular safety, tolerability, and efficacy of topical administration of ISV-303 compared with DuraSite Vehicle.
Phase:
Phase 3
Details
Lead Sponsor:
InSite Vision
Sun Pharma Global FZE
Treatments:
Bromfenac